Works matching IS 02724391 AND DT 2023 AND VI 84 AND IP 5

Results: 16

Toad venom bufadienolides and bufotoxins: An updated review.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 815, doi. 10.1002/ddr.22072

By:

Asrorov, Akmal M.;
Kayumov, Muzaffar;
Mukhamedov, Nurkhodja;
Yashinov, Ansor;
Mirakhmetova, Ziyoda;
Huang, Yongzhuo;
Yili, Abulimiti;
Aisa, Haji Akber;
Tashmukhamedov, Mugrajitdin;
Salikhov, Shavkat;
Mirzaakhmedov, Sharafitdin

Publication type:

Article

Azole derivatives inhibit wildtype butyrylcholinesterase and its common mutants.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 1018, doi. 10.1002/ddr.22071

By:

Sari, Suat;
Önder, Seda;
Akkaya, Didem;
Sabuncuoğlu, Suna;
Zengin, Merve;
Barut, Burak;
Karakurt, Arzu

Publication type:

Article

All‐trans retinoic acid inhibits oxidative stress via ACE2/Ang (1–7)/MasR pathway in renal tubular epithelial cells stimulated with high glucose.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 1008, doi. 10.1002/ddr.22070

By:

Zhu, Xiaojuan;
Mou, Zhixiang;
Han, Wei;
Chen, Lan

Publication type:

Article

Circular RNAs in the chemoresistance of triple‐negative breast cancer: A systematic review.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 805, doi. 10.1002/ddr.22069

By:

Wang, Hongmei;
Shan, Xuefeng;
Peng, Yang;
Zhou, Weiying

Publication type:

Article

Computational and experimental analyses of alanine racemase suggest new avenues for developing allosteric small‐molecule antibiotics.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 999, doi. 10.1002/ddr.22068

By:

van Wieren, Arie;
Durrant, Jacob D.;
Majumdar, Sudipta

Publication type:

Article

Dihydroartemisinin inhibited stem cell‐like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT/mTOR signaling.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 988, doi. 10.1002/ddr.22067

By:

Wang, Yujun;
Yang, Zhirong;
Zhu, Wanglong;
Chen, Yuzhuo;
He, Xingqiang;
Li, Jiaofeng;
Han, Zhengyu;
Yang, Yuhan;
Liu, Wei;
Zhang, Kun

Publication type:

Article

Synthesis and biological evaluation of novel 5‐substituted/unsubstituted triazolothiadiazines as tubulin depolymerizing and vascular disrupting agents with promising antitumor activity.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 975, doi. 10.1002/ddr.22066

By:

Huo, Xian‐Sen;
Tang‐Yang, Ji;
Zeng, Wen‐Bin;
Jian, Xie‐Er;
Ma, Xuan‐Xuan;
Yue‐Yang, Peng;
Wen‐Wei, You;
Zhao, Pei‐Liang

Publication type:

Article

Synthesis, biological evaluation, and molecular docking study of chromen‐linked hydrazine carbothioamides as potent α‐glucosidase inhibitors.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 962, doi. 10.1002/ddr.22065

By:

Basri, Rabia;
Ullah, Saeed;
Halim, Sobia Ahsan;
Alharthy, Rima D.;
Rauf, Umair;
Khan, Ajmal;
Hussain, Javid;
Al‐Ghafri, Ahmed;
Al‐Harrasi, Ahmed;
Shafiq, Zahid

Publication type:

Article

Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 937, doi. 10.1002/ddr.22064

By:

Eissa, Kholoud I.;
Kamel, Mona M.;
Mohamed, Lamia W.;
Doghish, Ahmed S.;
Alnajjar, Radwan;
Al‐Karmalawy, Ahmed A.;
Kassab, Asmaa E.

Publication type:

Article

Natural products and their analogues acting against Mycobacterium tuberculosis: A recent update.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 779, doi. 10.1002/ddr.22063

By:

Kumar, Gautam;
C, Amrutha

Publication type:

Article

Tilianin alleviates lipid deposition and fibrosis in mice with nonalcoholic steatohepatitis by activating the PPARα/Nnat axis.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 922, doi. 10.1002/ddr.22062

By:

Ke, Fan;
Wu, Xu;
Zheng, Jing;
Li, Cuihong

Publication type:

Article

Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 907, doi. 10.1002/ddr.22061

By:

Wang, Qi;
Wu, Hua;
Wu, Qingquan;
Zhong, Sheng

Publication type:

Article

Design, synthesis, anticancer, and antibacterial evaluation of some quinazolinone‐based derivatives as DHFR inhibitors.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 888, doi. 10.1002/ddr.22060

By:

Osman, Eman O.;
Emam, Soha H.;
Sonousi, Amr;
Kandil, Mai M.;
Abdou, Amr M.;
Hassan, Rasha A.

Publication type:

Article

Diaryl ether derivative inhibits GPX4 expression levels to induce ferroptosis in thyroid cancer cells.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 861, doi. 10.1002/ddr.22059

By:

Pamarthy, Deepika;
Behera, Santosh Kumar;
Swain, Sonam;
Yadav, Sanjay;
Suresh, Surisetti;
Jain, Nishant;
Bhadra, Manika Pal

Publication type:

Article

Design and synthesis of novel hexahydrobenzo[4,5]thieno[2,3‐d]pyrimidine derivatives as potential anticancer agents with antiangiogenic activity via VEGFR‐2 inhibition, and down‐regulation of PI3K/AKT/mTOR signaling pathway.

Published in:

Drug Development Research, 2023, v. 84, n. 5, p. 839, doi. 10.1002/ddr.22058

By:

Seif, Safaa E.;
Mahmoud, Zeinab;
Wardakhan, Wagnat W.;
Abdou, Amr M.;
Hassan, Rasha A.

Publication type:

Article

Issue Information.

Published in:: Drug Development Research, 2023, v. 84, n. 5, p. 777, doi. 10.1002/ddr.21947
Publication type:: Article